您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报（医学版） ›› 2017, Vol. 55 ›› Issue (5): 81-85.doi: 10.6040/j.issn.1671-7554.0.2016.1676

• 临床医学 • 上一篇    下一篇

来曲唑治疗不同体质量指数多囊卵巢综合征患者的临床效果

张素萍1,2,王泽1,周亚丽3, 李敬1,路西兰4,柏宏伟4,石玉华1   

  1. 1.山东大学附属生殖医院生殖科, 山东 济南 250001;2.邹城市人民医院妇科, 山东 邹城 273500;3.曹县县立医院妇产科, 山东 曹县 274400;4. 济南市中心医院生殖医学科, 山东 济南 250013
  • 收稿日期:2016-12-19 出版日期:2017-05-10 发布日期:2017-05-10
  • 通讯作者: 石玉华. E-mail:shiyuhua2003@126.com E-mail:shiyuhua2003@126.com
  • 基金资助:
    国家自然基金面上项目(81471428,81200423);山东省医药卫生科技发展计划项目(2014WS0122);山东省科技发展计划项目(2014GSF118148)

Clinical effects of body mass index on ovulation induction treatment with letrozole among women with polycystic ovary syndrome

ZHANG Suping1,2, WANG Ze1, ZHOU Yali3, LI Jing1, LU Xilan4, BAI Hongwei4, SHI Yuhua1   

  1. 1. Center for Reproductive Medicine, Provincial Hospital Affiliated to Shandong University, Jinan 250001, Shandong, China;
    2. Department of Gynaecology, Zoucheng Peoples Hospital, Zoucheng 273500, Shandong, China;
    3. Department of Obstertrics and Gynecology, Caoxian County Hospital, Caoxian 274400, Shandong, China;
    4. Center for Reproductive Medicine, Central Hospital Affiliated to Shandong University, Jinan 250013, Shandong, China
  • Received:2016-12-19 Online:2017-05-10 Published:2017-05-10

PDF (PC)

364

摘要： 目的 比较不同体质量指数(BMI)的多囊卵巢综合征(PCOS)患者使用来曲唑促排卵的临床效果。 方法 将2014年1月至2015年12月于山东大学附属生殖医院就诊的153例有生育要求的PCOS患者作为研究对象,根据BMI将患者分为肥胖型组71例和非肥胖型组82例。在患者月经第2~4天开始给予来曲唑5 mg,次/d×5 d促排卵监测并指导同房;比较两组间的促排卵效果。 结果 肥胖型组的血糖、胰岛素、甘油三酯、高密度脂蛋白及总胆固醇水平高于非肥胖型组(P=0.020, <0.001, 0.002, <0.001, 0.028),而给予绒促性素(HCG)日雌二醇水平低于非肥胖型组,差异均有统计学意义(P=0.026)。两组患者的优势卵泡数、排卵率、HCG日子宫内膜厚度和促黄体生成素、孕酮等激素水平、妊娠率、流产率及活产率等的比较差异均无统计学意义(P>0.05)。 结论 不同BMI的PCOS患者可选用来曲唑促排卵,其可提高周期排卵率及妊娠率,肥胖型PCOS患者临床效果与非肥胖型患者相似。

关键词: 活产率, 多囊卵巢综合征, 来曲唑, 体质量指数, 肥胖

Abstract: Objective To compare the clinical effects of body mass index(BMI)on ovulation induction treatment with letrozole among women with polycystic ovary syndrome(PCOS). Methods A total of 153 infertile PCOS women treated during Jan. 2014 and Dec. 2015 were enrolled. These women were divided into obese group(n=71)and non-obese group(n=82)according to their BMI. The stimulation was initiated by letrozole at a dose of 5mg daily for 5 days, beginning from day 2 to day 4 of the menstrual cycle. The ovulation induction outcomes of the two groups were compared. Results The obese group had significantly higher serum glucose, insulin, triglyceride, high density lipoprotein(HDL), and total cholesterol level than the non-obese group(P=0.020, <0.001, =0.002, <0.001, =0.028). On the day when human chorionic gonadotropin(HCG)was administered, estradiol(E2)was statistically lower in the obese group than in the non-obese group(P=0.026). There were no differences in the number of dominant follicles, ovulation rate, luteinizing hormone(LH)level on the HCG day, progesterone level, pregnancy rate, miscarriage rate and live birth rate between the two groups(P>0.05). Conclusion Letrozole is an effective ovulation induction agent for infertile PCOS women with different MBI by improving the ovulation and pregnancy rate.

Key words: Polycystic ovary syndrome, Letrozole, Body mass index, Live birth rate, Obesity

中图分类号: 

  • R588
[1] Norman RJ, Dewailly D, Legro RS, et al. Polycystic ovary syndrome[J]. Lancet, 2007, 370(9588): 685-697.
[2] Richard S, Robert G, Michael P, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome[J]. The New England, 2014, 371(2): 119-129.
[3] Roque M, Tostes AC, Valle M, et al. Letrozole versus clomiphene citrate in polycystic ovary syndrome: systematic review and meta-analysis[J]. Gynecol Endocrinol, 2015, 31(12): 917-921.
[4] 丁楠, 王芳, 简启亮, 等. 不同剂量来曲唑对多囊卵巢综合征患者疗效的 Meta 分析[J]. 生殖与避孕, 2015, 35(9): 626-633. DING Nan, WANG Fang, JIAN Qiliang, et al. A Meta-analysis of two different dosages of letrozole in women with polycystic ovary syndrome[J]. Reproduction & Contraception, 2015, 35(9): 626-633.
[5] 多囊卵巢综合征诊断中华人民共和国卫生行业标准[J]. 中华妇产科杂志, 2012, 47(1): 74-75.
[6] Stocco C. Aromatase expression in the ovary: hormonal and molecule regulation[J]. Steroids, 2008, 73(5): 473-487.
[7] Hickey TE, Marrocco DL, Gilchrist RB, et al. Interactions between androgen and growth factors in granulosa cell subtypes of porcine antral follicles[J]. Biol Reprod, 2004, 71(1): 45-52.
[8] 栾素娴, 马华刚, 孙银婷. 来曲唑促排卵对性激素水平的影响[J]. 生殖医学杂志, 2015, 24(2): 111-114. LUAN Suxian, MA Huagang, SUN Yinting. Impact of letrozole on sex hormone levels in ovulation induction[J]. Journal of Reproductive Medicine, 2015, 24(2): 111-114.
[9] McKnight KK, Nodler JL, Cooper JJ Jr, et al. Body mass index-associated differences in response to ovulation induction with letrozole[J]. Fertil Steril, 2011, 96(5): 1206-1208.
[10] 李晓芳, 孙宝治. 来曲唑对肥胖和非肥胖型PCOS病人促排卵的影响[J]. 青岛大学医学院学报, 2011, 47(6): 491-495. LI Xiaofang, SUN Baozhi. The effect of letrozole on ovarian stimulation in patients with obese or non-obese polycystic ovarian syndrome[J]. Acta Aacademiae Medicinae Qingdao Universitatis, 2011, 47(6): 491-495.
[11] Elnashar A, Fouad H, Eldosoky M, et al. Letrozole induction of ovulation in women with clomiphene citratere-sistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle-stimulating hormone ratio[J]. Fertil Steril, 2006, 85(2): 511-513.
[12] Xu XH, Shi YH, Cui YQ, et al. Endocrine and metabolic characteristics of polycystic ovary syndrome in Chinese women with different phenotypes[J]. Clinical Endocrinology(Oxford), 2012, 76(3): 425-430.
[13] Nahid L, Sirous K. Comparison of the effects of letrozole and clomiphene citrate for ovulation induction in infertile women with polycystic ovary syndrome[J]. Minerva ginecologica, 2012, 64(3): 253-258.
[14] 卢贝琳, 陈俊卿. 来曲唑和氯米芬对多囊卵巢综合征所致不孕患者子宫内膜及妊娠率的影响分析[J]. 中国性科学, 2016, 25(4): 126-128. LU Beilin, CHEN Junqing. Clinical efficacy of letrozole and clomiphene citrate on ovulation induction in the infertile women with polycystic ovary syndrome[J]. Chinese Journal of Human Sexuality, 2016, 25(4): 126-128.
[15] Casper RF, Mitwally MF. A historical perspective of aromatase inhibitors for ovulation induction[J]. Fertility Sterility, 2012, 98(6): 1352-1355.
[16] Pritts EA. Letrozole for ovulation induction and controlled ovarian hyperstimulation[J]. Curr Opin Obstet Gynecol, 2010, 22(4): 289-294.
[17] Rahmani E, Ahmadi S, Motamed N, et al. Dosage optimization for letrozole treatment in clomiphene-resistant patients with polycystic ovary syndrome a prospective interventional study[J]. Obstet Gynecol Int, 2012, 758508. doi: 10.1155/2012/758508. Epub 2012 Jan 16.
[18] Lim SS, Davies MJ, Norman RJ, et al. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis[J]. Hum Reprod Update, 2012, 18(6): 618-637.
[19] Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline[J]. J Clin Endocrinol Metab, 2013, 98(12): 4565-4592.
[20] Panidis D, Farmakiotis D, Rousso D, et al. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels[J]. Fertil Steril, 2008, 89(4): 899-906.
[21] Milone M, De Placido G, Musella M, et al. Incidence of successful pregnancy after weight loss interventions in infertile women: a systematic review and meta-analysis of the literature[J]. Obes Surg, 2016, 26(2): 443-451.
[22] Moran L, Tsagareli V, Norman R. Diet and IVF pilot study: short-term weight loss improves pregnancy rates in overweight/obese women undertaking IVF[J]. Aust N Z J Obstet Gynaecol, 2011, 51(5): 455-459.
[1] 张媛 李英敏 冯月秋 常彩云 潘华伟 王束玫. 血清脂联素水平与肥胖、胰岛素抵抗的关系探讨[J]. 山东大学学报(医学版), 2209, 47(6): 124-.
[2] 李涵,付婷婷,张磊,延冰,孙涛,郭峰,尹晓. 过氧化物酶增殖物激活受体γ激动剂对24例肥胖症患者米色脂肪细胞分化的影响[J]. 山东大学学报 (医学版), 2020, 1(9): 8-13.
[3] 刘晓菲,梁瀛,张丛溪,王娟,潘云,徐嘉蔚,常春,董亮. 92例哮喘患者血清瘦素与诱导痰嗜酸性粒细胞的关系[J]. 山东大学学报 (医学版), 2020, 1(9): 27-33.
[4] 扈艳雯,王志媛,郁万江,赵蕙琛,韩合理,徐志鹏,马红,张玉超,刘元涛. 52例肥胖患者脂肪分布与代谢综合征及糖代谢指标的相关性[J]. 山东大学学报 (医学版), 2020, 1(8): 101-106.
[5] 丁祥云,于清梅,张文芳,庄园,郝晶. 胰岛素样生长因子II在84例多囊卵巢综合征患者颗粒细胞中的表达和促排卵结局的相关性[J]. 山东大学学报 (医学版), 2020, 1(7): 60-66.
[6] 杨冬梓,麦卓瑶. 高龄多囊卵巢综合征患者的卵巢储备特点及其助孕结局[J]. 山东大学学报（医学版）, 2017, 55(1): 26-32.
[7] 贾月月,刘洪彬,李婧博,李敬,张江涛, 孙梅,石玉华. 多囊卵巢综合征患者颗粒细胞microRNA-200b的表达及影响[J]. 山东大学学报（医学版）, 2017, 55(1): 63-68.
[8] 李婧博,刘洪彬,贾月月,王泽,孙梅,石玉华. microRNA-183在PCOS胰岛素抵抗中的表达及其临床意义[J]. 山东大学学报（医学版）, 2017, 55(1): 69-74.
[9] 张琳,李敬,王泽,张江涛,马增香,石玉华. 多囊卵巢综合征患者促甲状腺激素对血糖、血脂的影响[J]. 山东大学学报（医学版）, 2017, 55(1): 80-84.
[10] 沙莎,Chowdhury Sumon Rahman,陈丽,何芹,张婧,范珊珊,孙磊. 利拉鲁肽对高脂诱导肥胖小鼠瘦素、脂肪分布及含量的影响[J]. 山东大学学报（医学版）, 2016, 54(8): 22-27.
[11] 刘瑞红,丁荔洁,薛付忠. 退休前后生活方式及肥胖指标的变化[J]. 山东大学学报（医学版）, 2016, 54(1): 80-85.
[12] 李燕, 汪翼, 乔秀芸, 张莉, 孙瑾. 不同抵抗素水平对血清游离脂肪酸的影响[J]. 山东大学学报（医学版）, 2015, 53(11): 6-9.
[13] 刘卫刚, 陆云, 李琳琳, 李筠青, 盛学文, 尹磊, 张功员, 赵景志. 河南省某地区人群肥胖易感性与神经肽Y及其受体基因多态性的关系[J]. 山东大学学报（医学版）, 2014, 52(8): 98-101.
[14] 王玮, 常康, 李晓冬, 郝桂敏. 胰岛素增敏剂对PCOS大鼠子宫内膜胰岛素受体底物表达的影响[J]. 山东大学学报（医学版）, 2014, 52(12): 24-29.
[15] 哈灵侠, 李向红. 多囊卵巢综合征患者卵泡液中GDF9和BMP15的表达及意义[J]. 山东大学学报（医学版）, 2014, 52(10): 77-80,95.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发